Super-enhancers are a specialized class of functional, non-coding RNA molecules transcribed directly from regions of the ...
Researchers at Carnegie Mellon University in Qatar (CMU Q) have discovered a genetic molecule that could provide new ...
The FDA has granted HAYA Therapeutics Fast Track Designation for HTX-001 for the treatment of symptomatic nonobstructive hypertrophic cardiomyopathy.
HTX-001 has not received approval from the FDA, European Medicines Agency, or any other regulatory authority.
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El ...
Manufacturers of a non-invasive saliva test say it can accurately diagnose endometriosis, but Australian experts warn there ...
You will be redirected to our submission process. The transcriptomic landscape of living cells is defined not only by the genes that are expressed, but by the intricate networks of coding and ...
Rugonersen, a potentially best-in-class antisense oligonucleotide (ASO) therapy in development for Angelman syndrome, advanced into the pivotal Phase 3 BEACON clinical trialAngelman syndrome affects ...
HAYA Therapeutics has announced full enrolment and dosing of the first cohort in its Phase I clinical trial of HTX-001, a long non-coding ribonucleic acid (lncRNA)-targeting therapy developed for ...
Scientists have just discovered an entirely new way that DNA can be synthesized. The business of constructing DNA (deoxyribonucleic acid, to give it its full name) usually requires a template that ...